

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.98691139 |
| 2 | synaptic vesicle maturation (GO:0016188) | 7.07504516 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.94471921 |
| 4 | * ensheathment of neurons (GO:0007272) | 6.85101527 |
| 5 | * axon ensheathment (GO:0008366) | 6.85101527 |
| 6 | * myelination (GO:0042552) | 6.81281708 |
| 7 | glutamate secretion (GO:0014047) | 6.47801917 |
| 8 | cellular potassium ion homeostasis (GO:0030007) | 5.97399572 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.91796119 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.60722461 |
| 11 | sodium ion export (GO:0071436) | 5.58395442 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.53981677 |
| 13 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.47437371 |
| 14 | myelin maintenance (GO:0043217) | 5.26450549 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.17792002 |
| 16 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.14865663 |
| 17 | locomotory exploration behavior (GO:0035641) | 5.10550344 |
| 18 | cholesterol biosynthetic process (GO:0006695) | 5.06794830 |
| 19 | negative regulation of neurotransmitter transport (GO:0051589) | 4.91685480 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.81873221 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.77793979 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.74640574 |
| 23 | regulation of collateral sprouting (GO:0048670) | 4.68635027 |
| 24 | oligodendrocyte differentiation (GO:0048709) | 4.62615482 |
| 25 | L-amino acid import (GO:0043092) | 4.58192175 |
| 26 | establishment of mitochondrion localization (GO:0051654) | 4.52748210 |
| 27 | potassium ion homeostasis (GO:0055075) | 4.51129793 |
| 28 | glycerophospholipid catabolic process (GO:0046475) | 4.50259280 |
| 29 | negative regulation of protein localization to cell surface (GO:2000009) | 4.50009421 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.48172248 |
| 31 | response to methylmercury (GO:0051597) | 4.47733927 |
| 32 | sterol biosynthetic process (GO:0016126) | 4.47251908 |
| 33 | postsynaptic membrane organization (GO:0001941) | 4.39851182 |
| 34 | potassium ion import (GO:0010107) | 4.37998777 |
| 35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.34733655 |
| 36 | creatine metabolic process (GO:0006600) | 4.33811847 |
| 37 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.22664503 |
| 38 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.15318693 |
| 39 | presynaptic membrane organization (GO:0097090) | 4.14169366 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.13400649 |
| 41 | vocalization behavior (GO:0071625) | 4.12859055 |
| 42 | photoreceptor cell differentiation (GO:0046530) | 4.12275145 |
| 43 | eye photoreceptor cell differentiation (GO:0001754) | 4.12275145 |
| 44 | exploration behavior (GO:0035640) | 4.08062556 |
| 45 | amyloid precursor protein metabolic process (GO:0042982) | 4.06190670 |
| 46 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.04639218 |
| 47 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.02374174 |
| 48 | response to redox state (GO:0051775) | 4.00480811 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.00284122 |
| 50 | apical protein localization (GO:0045176) | 4.00083715 |
| 51 | positive regulation of synapse maturation (GO:0090129) | 3.96991164 |
| 52 | neurotransmitter transport (GO:0006836) | 3.96972639 |
| 53 | isoprenoid biosynthetic process (GO:0008299) | 3.96867449 |
| 54 | asymmetric protein localization (GO:0008105) | 3.96137007 |
| 55 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.84863925 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.81483584 |
| 57 | import into cell (GO:0098657) | 3.80992976 |
| 58 | synaptic transmission, glutamatergic (GO:0035249) | 3.80683600 |
| 59 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.76148643 |
| 60 | regulation of synaptic plasticity (GO:0048167) | 3.73152455 |
| 61 | acidic amino acid transport (GO:0015800) | 3.72303480 |
| 62 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.72087036 |
| 63 | neuromuscular process controlling balance (GO:0050885) | 3.66769905 |
| 64 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.66293044 |
| 65 | peripheral nervous system axon ensheathment (GO:0032292) | 3.63925355 |
| 66 | myelination in peripheral nervous system (GO:0022011) | 3.63925355 |
| 67 | glutamate receptor signaling pathway (GO:0007215) | 3.62586675 |
| 68 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.62149127 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.60706133 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.60349211 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.59868010 |
| 72 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.58485750 |
| 73 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.56455176 |
| 74 | cellular sodium ion homeostasis (GO:0006883) | 3.56397816 |
| 75 | long-term synaptic potentiation (GO:0060291) | 3.55768231 |
| 76 | cell communication by electrical coupling (GO:0010644) | 3.54918361 |
| 77 | regulation of neurotransmitter secretion (GO:0046928) | 3.54716892 |
| 78 | positive regulation of membrane potential (GO:0045838) | 3.52167230 |
| 79 | neuron-neuron synaptic transmission (GO:0007270) | 3.51981885 |
| 80 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.51930213 |
| 81 | negative regulation of inclusion body assembly (GO:0090084) | 3.51577324 |
| 82 | response to lipoprotein particle (GO:0055094) | 3.51488206 |
| 83 | positive regulation of dendritic spine development (GO:0060999) | 3.49841202 |
| 84 | amino acid import (GO:0043090) | 3.49219481 |
| 85 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.48525398 |
| 86 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.47736703 |
| 87 | * substantia nigra development (GO:0021762) | 3.45383762 |
| 88 | regulation of ARF protein signal transduction (GO:0032012) | 3.44277895 |
| 89 | protein palmitoylation (GO:0018345) | 3.41667727 |
| 90 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.38739273 |
| 91 | adhesion of symbiont to host cell (GO:0044650) | 3.38110294 |
| 92 | virion attachment to host cell (GO:0019062) | 3.38110294 |
| 93 | protein localization to synapse (GO:0035418) | 3.37854514 |
| 94 | membrane tubulation (GO:0097320) | 3.35626732 |
| 95 | regulation of neurotransmitter transport (GO:0051588) | 3.34456865 |
| 96 | L-glutamate transport (GO:0015813) | 3.31587906 |
| 97 | gamma-aminobutyric acid transport (GO:0015812) | 3.30737945 |
| 98 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.29349953 |
| 99 | adult walking behavior (GO:0007628) | 3.29022400 |
| 100 | neuron cell-cell adhesion (GO:0007158) | 3.28887117 |
| 101 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.27643100 |
| 102 | long-term memory (GO:0007616) | 3.27343514 |
| 103 | regulation of lipoprotein metabolic process (GO:0050746) | 3.26079708 |
| 104 | neuron remodeling (GO:0016322) | 3.25589105 |
| 105 | synaptic vesicle endocytosis (GO:0048488) | 3.24496000 |
| 106 | limb bud formation (GO:0060174) | 3.24105749 |
| 107 | negative regulation of axonogenesis (GO:0050771) | 3.21901597 |
| 108 | transmission of nerve impulse (GO:0019226) | 3.21199274 |
| 109 | magnesium ion transport (GO:0015693) | 3.20828761 |
| 110 | regulation of synapse structural plasticity (GO:0051823) | 3.18346980 |
| 111 | regulation of postsynaptic membrane potential (GO:0060078) | 3.17403404 |
| 112 | * long-chain fatty acid biosynthetic process (GO:0042759) | 3.17046459 |
| 113 | GPI anchor biosynthetic process (GO:0006506) | 3.15583405 |
| 114 | regulation of synapse maturation (GO:0090128) | 3.13580370 |
| 115 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.11423299 |
| 116 | regulation of dendritic spine development (GO:0060998) | 3.11134275 |
| 117 | regulation of synaptic transmission (GO:0050804) | 3.10744568 |
| 118 | very long-chain fatty acid metabolic process (GO:0000038) | 3.09371188 |
| 119 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.07730813 |
| 120 | GPI anchor metabolic process (GO:0006505) | 3.07528918 |
| 121 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.05846839 |
| 122 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.04715008 |
| 123 | positive regulation of Rap GTPase activity (GO:0032854) | 3.04086743 |
| 124 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.02404728 |
| 125 | regulation of vesicle fusion (GO:0031338) | 3.00143172 |
| 126 | cellular response to epinephrine stimulus (GO:0071872) | 2.98171985 |
| 127 | astrocyte differentiation (GO:0048708) | 2.97684796 |
| 128 | auditory behavior (GO:0031223) | 2.97049935 |
| 129 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.96444160 |
| 130 | neurotransmitter uptake (GO:0001504) | 2.96413889 |
| 131 | glycosylceramide metabolic process (GO:0006677) | 2.95648784 |
| 132 | membrane depolarization during action potential (GO:0086010) | 2.92382916 |
| 133 | layer formation in cerebral cortex (GO:0021819) | 2.92339973 |
| 134 | amyloid precursor protein catabolic process (GO:0042987) | 2.91587649 |
| 135 | phosphorelay signal transduction system (GO:0000160) | 2.90807840 |
| 136 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.90668360 |
| 137 | positive regulation of action potential (GO:0045760) | 2.90616173 |
| 138 | membrane assembly (GO:0071709) | 2.89809949 |
| 139 | membrane depolarization (GO:0051899) | 2.89416099 |
| 140 | peripheral nervous system development (GO:0007422) | 2.86948307 |
| 141 | neuronal action potential propagation (GO:0019227) | 2.84456607 |
| 142 | negative regulation of axon extension (GO:0030517) | 2.82845843 |
| 143 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.82814821 |
| 144 | negative regulation of JUN kinase activity (GO:0043508) | 2.82718046 |
| 145 | neuronal ion channel clustering (GO:0045161) | 2.82674881 |
| 146 | nucleotide transmembrane transport (GO:1901679) | 2.81295334 |
| 147 | peptidyl-cysteine modification (GO:0018198) | 2.78588782 |
| 148 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.76055335 |
| 149 | protein neddylation (GO:0045116) | 2.75600465 |
| 150 | thioester biosynthetic process (GO:0035384) | 2.74853962 |
| 151 | acyl-CoA biosynthetic process (GO:0071616) | 2.74853962 |
| 152 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.73671446 |
| 153 | enteric nervous system development (GO:0048484) | 2.71921041 |
| 154 | response to epinephrine (GO:0071871) | 2.70607835 |
| 155 | organ growth (GO:0035265) | 2.70504468 |
| 156 | positive regulation of glial cell differentiation (GO:0045687) | 2.70381800 |
| 157 | nerve growth factor signaling pathway (GO:0038180) | 2.69770983 |
| 158 | iron coordination entity transport (GO:1901678) | 2.64046414 |
| 159 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.62662407 |
| 160 | positive regulation of gliogenesis (GO:0014015) | 2.54982941 |
| 161 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.54089986 |
| 162 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.54089986 |
| 163 | glial cell differentiation (GO:0010001) | 2.54019394 |
| 164 | cellular response to monoamine stimulus (GO:0071868) | 2.53934767 |
| 165 | cellular response to catecholamine stimulus (GO:0071870) | 2.53934767 |
| 166 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.49193561 |
| 167 | regulation of dopamine metabolic process (GO:0042053) | 2.47673328 |
| 168 | regulation of catecholamine metabolic process (GO:0042069) | 2.47673328 |
| 169 | heme transport (GO:0015886) | 2.47529728 |
| 170 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.46834265 |
| 171 | cranial nerve development (GO:0021545) | 2.46463846 |
| 172 | cerebellar granule cell differentiation (GO:0021707) | 2.46448783 |
| 173 | neuron recognition (GO:0008038) | 2.44431729 |
| 174 | response to lead ion (GO:0010288) | 2.41553100 |
| 175 | adhesion of symbiont to host (GO:0044406) | 2.40549649 |
| 176 | microtubule polymerization or depolymerization (GO:0031109) | 2.40006570 |
| 177 | * axon ensheathment in central nervous system (GO:0032291) | 10.1836271 |
| 178 | * central nervous system myelination (GO:0022010) | 10.1836271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.29150828 |
| 2 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.26560997 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.80008039 |
| 4 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.76145456 |
| 5 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.66474580 |
| 6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.66134177 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.47003871 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.39526008 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38161004 |
| 10 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.36757849 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.35668450 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.27477341 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.12653434 |
| 14 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.11868089 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.11390347 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05501377 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02693789 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00383505 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00383505 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.99855725 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97075567 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95467508 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.92686814 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.91110726 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.89126659 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87477221 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.86871183 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.83700433 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81677335 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.81229677 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73867460 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69032237 |
| 33 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.68531617 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.66803815 |
| 35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.62741254 |
| 36 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.62084854 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61897880 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61423872 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.60469091 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56761680 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.55415825 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55364920 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52496079 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.50694837 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49986590 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48305019 |
| 47 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.47910853 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47383438 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46424889 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43807788 |
| 51 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40389093 |
| 52 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39143039 |
| 53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.39002093 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38245443 |
| 55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38182098 |
| 56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35965359 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.35814089 |
| 58 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.35731400 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34796158 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34622800 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32042398 |
| 62 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31645931 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31580542 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31147210 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30576296 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29396522 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26247434 |
| 68 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.26119067 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26033156 |
| 70 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24277675 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22278172 |
| 72 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.21311201 |
| 73 | AR_19668381_ChIP-Seq_PC3_Human | 1.20541444 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20526487 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20526487 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20169666 |
| 77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19116488 |
| 78 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17790230 |
| 79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.16032932 |
| 80 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.14351211 |
| 81 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14271307 |
| 82 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13108993 |
| 83 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12469496 |
| 84 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11764378 |
| 85 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10619058 |
| 86 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.08887786 |
| 87 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.08522411 |
| 88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08449075 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07852460 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07740772 |
| 91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07657313 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07031793 |
| 93 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05997738 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05863979 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05013900 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04587161 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04352479 |
| 98 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03439069 |
| 99 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02774023 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02701320 |
| 101 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01805030 |
| 102 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01401341 |
| 103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01009905 |
| 104 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00613577 |
| 105 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00109861 |
| 106 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99801699 |
| 107 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99617598 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99582525 |
| 109 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98922460 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98112091 |
| 111 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97981585 |
| 112 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97832196 |
| 113 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97744599 |
| 114 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97692748 |
| 115 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95697860 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94957340 |
| 117 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.94858744 |
| 118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93988354 |
| 119 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.92776994 |
| 120 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92664823 |
| 121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92224246 |
| 122 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91902993 |
| 123 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91862770 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91566275 |
| 125 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91044097 |
| 126 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91044097 |
| 127 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.90840204 |
| 128 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89925103 |
| 129 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89052047 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88839997 |
| 131 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88303218 |
| 132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87818300 |
| 133 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87781471 |
| 134 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87172937 |
| 135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87088342 |
| 136 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86870918 |
| 137 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.86738099 |
| 138 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86181951 |
| 139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86134652 |
| 140 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.85752949 |
| 141 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85707540 |
| 142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84947995 |
| 143 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84894078 |
| 144 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83846806 |
| 145 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81290379 |
| 146 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.81119790 |
| 147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80822782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0000920_abnormal_myelination | 5.43679298 |
| 2 | MP0003880_abnormal_central_pattern | 4.19754346 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.40588326 |
| 4 | MP0004270_analgesia | 3.29078889 |
| 5 | MP0004742_abnormal_vestibular_system | 2.89216570 |
| 6 | MP0003329_amyloid_beta_deposits | 2.84511009 |
| 7 | MP0004885_abnormal_endolymph | 2.76465735 |
| 8 | MP0003136_yellow_coat_color | 2.68204542 |
| 9 | MP0005171_absent_coat_pigmentation | 2.67134552 |
| 10 | MP0001905_abnormal_dopamine_level | 2.62526763 |
| 11 | * MP0002272_abnormal_nervous_system | 2.50504045 |
| 12 | * MP0003690_abnormal_glial_cell | 2.42947786 |
| 13 | MP0004142_abnormal_muscle_tone | 2.39481981 |
| 14 | MP0001485_abnormal_pinna_reflex | 2.29321302 |
| 15 | MP0005409_darkened_coat_color | 2.28866828 |
| 16 | * MP0003634_abnormal_glial_cell | 2.26544885 |
| 17 | MP0000778_abnormal_nervous_system | 2.25817710 |
| 18 | * MP0001486_abnormal_startle_reflex | 2.23899515 |
| 19 | * MP0002064_seizures | 2.23111589 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 2.16368413 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.03536814 |
| 22 | MP0005410_abnormal_fertilization | 1.98937461 |
| 23 | MP0009046_muscle_twitch | 1.92552680 |
| 24 | MP0003632_abnormal_nervous_system | 1.92327173 |
| 25 | MP0009745_abnormal_behavioral_response | 1.89199735 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 1.85538036 |
| 27 | MP0000462_abnormal_digestive_system | 1.82933019 |
| 28 | MP0001984_abnormal_olfaction | 1.82557875 |
| 29 | * MP0002229_neurodegeneration | 1.79486250 |
| 30 | MP0003879_abnormal_hair_cell | 1.78935474 |
| 31 | MP0002734_abnormal_mechanical_nocicepti | 1.75257613 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.74281564 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.72414922 |
| 34 | MP0004381_abnormal_hair_follicle | 1.65718136 |
| 35 | MP0004043_abnormal_pH_regulation | 1.62447893 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.59374726 |
| 37 | MP0004134_abnormal_chest_morphology | 1.59341551 |
| 38 | MP0000383_abnormal_hair_follicle | 1.59274844 |
| 39 | MP0005451_abnormal_body_composition | 1.59189089 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.57011115 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.54761779 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.52462624 |
| 43 | MP0003631_nervous_system_phenotype | 1.50594036 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.49771555 |
| 45 | MP0003787_abnormal_imprinting | 1.48797168 |
| 46 | MP0000955_abnormal_spinal_cord | 1.48516781 |
| 47 | MP0000604_amyloidosis | 1.47370265 |
| 48 | * MP0002882_abnormal_neuron_morphology | 1.39188016 |
| 49 | MP0002063_abnormal_learning/memory/cond | 1.38568166 |
| 50 | MP0008260_abnormal_autophagy | 1.32681052 |
| 51 | MP0003633_abnormal_nervous_system | 1.31225863 |
| 52 | MP0001970_abnormal_pain_threshold | 1.31094705 |
| 53 | MP0001963_abnormal_hearing_physiology | 1.30037597 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.28641428 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.28103523 |
| 56 | * MP0002066_abnormal_motor_capabilities/c | 1.27759249 |
| 57 | MP0004147_increased_porphyrin_level | 1.23365986 |
| 58 | MP0003123_paternal_imprinting | 1.18353926 |
| 59 | MP0000747_muscle_weakness | 1.17690645 |
| 60 | * MP0002752_abnormal_somatic_nervous | 1.15062213 |
| 61 | MP0005167_abnormal_blood-brain_barrier | 1.14753997 |
| 62 | MP0003195_calcinosis | 1.14209631 |
| 63 | MP0005623_abnormal_meninges_morphology | 1.13203105 |
| 64 | MP0001299_abnormal_eye_distance/ | 1.11828242 |
| 65 | MP0001346_abnormal_lacrimal_gland | 1.09376456 |
| 66 | MP0000566_synostosis | 1.09351192 |
| 67 | MP0001661_extended_life_span | 1.08847922 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.08348608 |
| 69 | MP0002733_abnormal_thermal_nociception | 1.06499219 |
| 70 | MP0000647_abnormal_sebaceous_gland | 0.99808974 |
| 71 | MP0003938_abnormal_ear_development | 0.99071365 |
| 72 | MP0006276_abnormal_autonomic_nervous | 0.98856210 |
| 73 | MP0001968_abnormal_touch/_nociception | 0.97398165 |
| 74 | MP0003075_altered_response_to | 0.97390259 |
| 75 | * MP0001529_abnormal_vocalization | 0.96874666 |
| 76 | MP0003122_maternal_imprinting | 0.96556828 |
| 77 | MP0001851_eye_inflammation | 0.94793873 |
| 78 | MP0000762_abnormal_tongue_morphology | 0.94570739 |
| 79 | MP0001177_atelectasis | 0.93443800 |
| 80 | * MP0005195_abnormal_posterior_eye | 0.93387521 |
| 81 | MP0008874_decreased_physiological_sensi | 0.88931990 |
| 82 | MP0003937_abnormal_limbs/digits/tail_de | 0.87748742 |
| 83 | MP0002295_abnormal_pulmonary_circulatio | 0.86790108 |
| 84 | * MP0008569_lethality_at_weaning | 0.85802924 |
| 85 | MP0002822_catalepsy | 0.85438018 |
| 86 | MP0000026_abnormal_inner_ear | 0.85259374 |
| 87 | MP0000569_abnormal_digit_pigmentation | 0.84417749 |
| 88 | MP0005058_abnormal_lysosome_morphology | 0.83840830 |
| 89 | * MP0004924_abnormal_behavior | 0.83680595 |
| 90 | * MP0005386_behavior/neurological_phenoty | 0.83680595 |
| 91 | MP0001501_abnormal_sleep_pattern | 0.82998372 |
| 92 | * MP0002152_abnormal_brain_morphology | 0.82707684 |
| 93 | MP0005408_hypopigmentation | 0.82428009 |
| 94 | MP0002735_abnormal_chemical_nociception | 0.82339993 |
| 95 | MP0005253_abnormal_eye_physiology | 0.80635034 |
| 96 | MP0002736_abnormal_nociception_after | 0.80341555 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.78971182 |
| 98 | MP0002184_abnormal_innervation | 0.77215756 |
| 99 | MP0006072_abnormal_retinal_apoptosis | 0.74177409 |
| 100 | MP0002557_abnormal_social/conspecific_i | 0.71812413 |
| 101 | MP0002090_abnormal_vision | 0.71610533 |
| 102 | MP0001348_abnormal_lacrimal_gland | 0.71423753 |
| 103 | MP0001502_abnormal_circadian_rhythm | 0.70655855 |
| 104 | MP0000579_abnormal_nail_morphology | 0.70607565 |
| 105 | MP0000467_abnormal_esophagus_morphology | 0.69588259 |
| 106 | MP0006082_CNS_inflammation | 0.67384140 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 0.67357780 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.66266316 |
| 109 | MP0004036_abnormal_muscle_relaxation | 0.65908496 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.64075141 |
| 111 | MP0002069_abnormal_eating/drinking_beha | 0.63593206 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.62541044 |
| 113 | MP0001727_abnormal_embryo_implantation | 0.60591506 |
| 114 | MP0000631_abnormal_neuroendocrine_gland | 0.60375788 |
| 115 | MP0008438_abnormal_cutaneous_collagen | 0.60054728 |
| 116 | MP0002133_abnormal_respiratory_system | 0.59101267 |
| 117 | MP0002909_abnormal_adrenal_gland | 0.59097181 |
| 118 | MP0005535_abnormal_body_temperature | 0.58554296 |
| 119 | MP0003045_fibrosis | 0.58065793 |
| 120 | * MP0010769_abnormal_survival | 0.55349693 |
| 121 | MP0001943_abnormal_respiration | 0.53125947 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.51943173 |
| 123 | * MP0002082_postnatal_lethality | 0.51562707 |
| 124 | * MP0010770_preweaning_lethality | 0.51562707 |
| 125 | * MP0010768_mortality/aging | 0.51512726 |
| 126 | MP0003956_abnormal_body_size | 0.47680163 |
| 127 | MP0005388_respiratory_system_phenotype | 0.47047055 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.46102792 |
| 129 | MP0002089_abnormal_postnatal_growth/wei | 0.45910543 |
| 130 | * MP0003861_abnormal_nervous_system | 0.43345443 |
| 131 | MP0004130_abnormal_muscle_cell | 0.42466789 |
| 132 | MP0008872_abnormal_physiological_respon | 0.42433859 |
| 133 | MP0001731_abnormal_postnatal_growth | 0.42044523 |
| 134 | MP0003283_abnormal_digestive_organ | 0.40835167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.57609325 |
| 2 | Focal seizures (HP:0007359) | 5.26564720 |
| 3 | Parakeratosis (HP:0001036) | 5.10515695 |
| 4 | Sensory axonal neuropathy (HP:0003390) | 4.97175600 |
| 5 | Peripheral hypomyelination (HP:0007182) | 4.84256133 |
| 6 | Cerebral inclusion bodies (HP:0100314) | 4.72514407 |
| 7 | Febrile seizures (HP:0002373) | 4.69657841 |
| 8 | Abnormality of binocular vision (HP:0011514) | 4.69180796 |
| 9 | Diplopia (HP:0000651) | 4.69180796 |
| 10 | Atonic seizures (HP:0010819) | 4.46959811 |
| 11 | Epileptic encephalopathy (HP:0200134) | 4.37318473 |
| 12 | Cerebral hypomyelination (HP:0006808) | 4.22211590 |
| 13 | Onion bulb formation (HP:0003383) | 4.00096801 |
| 14 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.95497426 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.82005851 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.58041628 |
| 17 | Abnormal auditory evoked potentials (HP:0006958) | 3.57113840 |
| 18 | Termporal pattern (HP:0011008) | 3.56708183 |
| 19 | Insidious onset (HP:0003587) | 3.56708183 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.51099134 |
| 21 | Alacrima (HP:0000522) | 3.47799652 |
| 22 | Postural instability (HP:0002172) | 3.47037118 |
| 23 | Intention tremor (HP:0002080) | 3.44169214 |
| 24 | Increased serum pyruvate (HP:0003542) | 3.34760023 |
| 25 | Abnormality of glycolysis (HP:0004366) | 3.34760023 |
| 26 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.13647667 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.13507486 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 3.06820714 |
| 29 | Visual hallucinations (HP:0002367) | 3.06646317 |
| 30 | Absence seizures (HP:0002121) | 3.06607567 |
| 31 | Obstructive sleep apnea (HP:0002870) | 3.06251734 |
| 32 | Retinal dysplasia (HP:0007973) | 3.03049649 |
| 33 | Truncal ataxia (HP:0002078) | 3.00717978 |
| 34 | Dialeptic seizures (HP:0011146) | 2.99092135 |
| 35 | Slow saccadic eye movements (HP:0000514) | 2.98117758 |
| 36 | Hemiplegia (HP:0002301) | 2.97339827 |
| 37 | Torticollis (HP:0000473) | 2.97047205 |
| 38 | Limb dystonia (HP:0002451) | 2.95585919 |
| 39 | * Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.95580938 |
| 40 | * Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.95580938 |
| 41 | Neuronal loss in central nervous system (HP:0002529) | 2.91144623 |
| 42 | Myokymia (HP:0002411) | 2.90915664 |
| 43 | Ankle clonus (HP:0011448) | 2.90730229 |
| 44 | Papilledema (HP:0001085) | 2.89198873 |
| 45 | Hypoplastic pelvis (HP:0008839) | 2.88324806 |
| 46 | Mutism (HP:0002300) | 2.86793059 |
| 47 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.86540249 |
| 48 | Tetraplegia (HP:0002445) | 2.84920798 |
| 49 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.82468759 |
| 50 | Anteriorly placed anus (HP:0001545) | 2.82372480 |
| 51 | Dysdiadochokinesis (HP:0002075) | 2.78680735 |
| 52 | Premature skin wrinkling (HP:0100678) | 2.74961615 |
| 53 | * Spastic gait (HP:0002064) | 2.74263504 |
| 54 | Decreased lacrimation (HP:0000633) | 2.73425349 |
| 55 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.72481804 |
| 56 | Cerebral hemorrhage (HP:0001342) | 2.71964689 |
| 57 | Spastic paraparesis (HP:0002313) | 2.71715121 |
| 58 | Akinesia (HP:0002304) | 2.71700672 |
| 59 | * Dysmetria (HP:0001310) | 2.70490471 |
| 60 | Absent septum pellucidum (HP:0001331) | 2.68915630 |
| 61 | CNS hypomyelination (HP:0003429) | 2.66749595 |
| 62 | Annular pancreas (HP:0001734) | 2.66402444 |
| 63 | Depression (HP:0000716) | 2.65451354 |
| 64 | Insomnia (HP:0100785) | 2.65016317 |
| 65 | Hemiparesis (HP:0001269) | 2.60001523 |
| 66 | Sleep apnea (HP:0010535) | 2.59239146 |
| 67 | Clumsiness (HP:0002312) | 2.58517747 |
| 68 | Delusions (HP:0000746) | 2.56801324 |
| 69 | Thickened helices (HP:0000391) | 2.56765527 |
| 70 | Apathy (HP:0000741) | 2.56239673 |
| 71 | Increased circulating renin level (HP:0000848) | 2.53359633 |
| 72 | Morphological abnormality of the inner ear (HP:0011390) | 2.53314074 |
| 73 | Bradykinesia (HP:0002067) | 2.53212237 |
| 74 | * Lower limb muscle weakness (HP:0007340) | 2.51258408 |
| 75 | Rigidity (HP:0002063) | 2.51174324 |
| 76 | Abnormality of the periventricular white matter (HP:0002518) | 2.47624258 |
| 77 | * Leukodystrophy (HP:0002415) | 2.46797324 |
| 78 | Status epilepticus (HP:0002133) | 2.46748757 |
| 79 | Autoamputation (HP:0001218) | 2.46465447 |
| 80 | Pheochromocytoma (HP:0002666) | 2.46109650 |
| 81 | Rapidly progressive (HP:0003678) | 2.45324533 |
| 82 | Split foot (HP:0001839) | 2.42426581 |
| 83 | Bundle branch block (HP:0011710) | 2.42226327 |
| 84 | Anxiety (HP:0000739) | 2.41746201 |
| 85 | Focal dystonia (HP:0004373) | 2.36755446 |
| 86 | Poor eye contact (HP:0000817) | 2.34039553 |
| 87 | White forelock (HP:0002211) | 2.31081672 |
| 88 | Metabolic alkalosis (HP:0200114) | 2.29943919 |
| 89 | Diminished motivation (HP:0000745) | 2.27725815 |
| 90 | Patchy hypopigmentation of hair (HP:0011365) | 2.27561477 |
| 91 | Coronal craniosynostosis (HP:0004440) | 2.27106481 |
| 92 | Abnormality of the septum pellucidum (HP:0007375) | 2.26275083 |
| 93 | Hypomagnesemia (HP:0002917) | 2.25733738 |
| 94 | Hepatosplenomegaly (HP:0001433) | 2.25169022 |
| 95 | Craniofacial dystonia (HP:0012179) | 2.25014459 |
| 96 | Epileptiform EEG discharges (HP:0011182) | 2.24245341 |
| 97 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.22061792 |
| 98 | Aplasia of the phalanges of the hand (HP:0009802) | 2.22061792 |
| 99 | Aplasia involving bones of the extremities (HP:0009825) | 2.22061792 |
| 100 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.21037435 |
| 101 | Abnormality of the lower motor neuron (HP:0002366) | 2.18398912 |
| 102 | Neuroendocrine neoplasm (HP:0100634) | 2.17365525 |
| 103 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.16971019 |
| 104 | Turricephaly (HP:0000262) | 2.14635443 |
| 105 | Hypoplasia of the iris (HP:0007676) | 2.13987958 |
| 106 | Spastic tetraparesis (HP:0001285) | 2.13384377 |
| 107 | Cupped ear (HP:0000378) | 2.12728060 |
| 108 | Renal Fanconi syndrome (HP:0001994) | 2.11775661 |
| 109 | Impaired smooth pursuit (HP:0007772) | 2.10937145 |
| 110 | * Choreoathetosis (HP:0001266) | 2.10873618 |
| 111 | Foot dorsiflexor weakness (HP:0009027) | 2.10739502 |
| 112 | Infantile muscular hypotonia (HP:0008947) | 2.10420767 |
| 113 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.09483551 |
| 114 | Esophageal atresia (HP:0002032) | 2.08417607 |
| 115 | Methylmalonic acidemia (HP:0002912) | 2.06836710 |
| 116 | Partial agenesis of the corpus callosum (HP:0001338) | 2.05776451 |
| 117 | Hypokalemic alkalosis (HP:0001949) | 2.05636051 |
| 118 | Poor speech (HP:0002465) | 2.04499614 |
| 119 | Bronchomalacia (HP:0002780) | 2.03322080 |
| 120 | Impaired vibratory sensation (HP:0002495) | 2.03213315 |
| 121 | Impaired social interactions (HP:0000735) | 2.02269420 |
| 122 | Abnormal social behavior (HP:0012433) | 2.02269420 |
| 123 | Muscle fiber splitting (HP:0003555) | 2.01763653 |
| 124 | Abnormality of saccadic eye movements (HP:0000570) | 2.01547281 |
| 125 | Adrenal hypoplasia (HP:0000835) | 1.98725349 |
| 126 | Megalencephaly (HP:0001355) | 1.98646239 |
| 127 | Axonal loss (HP:0003447) | 1.97916100 |
| 128 | Partial duplication of thumb phalanx (HP:0009944) | 1.97549341 |
| 129 | Decreased motor nerve conduction velocity (HP:0003431) | 1.97316623 |
| 130 | Synostosis involving the elbow (HP:0003938) | 1.97218845 |
| 131 | Humeroradial synostosis (HP:0003041) | 1.97218845 |
| 132 | Memory impairment (HP:0002354) | 1.96646087 |
| 133 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.96200096 |
| 134 | * Abnormality of the corticospinal tract (HP:0002492) | 1.96078996 |
| 135 | Paraparesis (HP:0002385) | 1.95309842 |
| 136 | Clonus (HP:0002169) | 1.94010226 |
| 137 | Amyotrophic lateral sclerosis (HP:0007354) | 1.93269912 |
| 138 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92832503 |
| 139 | Action tremor (HP:0002345) | 1.92452795 |
| 140 | Abnormality of the foot musculature (HP:0001436) | 1.90526161 |
| 141 | Urinary incontinence (HP:0000020) | 1.87773044 |
| 142 | Vaginal atresia (HP:0000148) | 1.87772117 |
| 143 | Acute necrotizing encephalopathy (HP:0006965) | 1.87288223 |
| 144 | Septo-optic dysplasia (HP:0100842) | 1.87077325 |
| 145 | 3-Methylglutaconic aciduria (HP:0003535) | 1.86726675 |
| 146 | Anomalous pulmonary venous return (HP:0010772) | 1.86238893 |
| 147 | Broad-based gait (HP:0002136) | 1.86138518 |
| 148 | Stereotypic behavior (HP:0000733) | 1.84983457 |
| 149 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.83352833 |
| 150 | Hammertoe (HP:0001765) | 1.83296292 |
| 151 | Hypophosphatemic rickets (HP:0004912) | 1.82774157 |
| 152 | Overriding aorta (HP:0002623) | 1.82549676 |
| 153 | Gowers sign (HP:0003391) | 1.81481004 |
| 154 | Erythroderma (HP:0001019) | 1.80869912 |
| 155 | Genital tract atresia (HP:0001827) | 1.77213267 |
| 156 | Generalized myoclonic seizures (HP:0002123) | 1.77051089 |
| 157 | Focal motor seizures (HP:0011153) | 1.76405732 |
| 158 | Steppage gait (HP:0003376) | 1.75378951 |
| 159 | Distal sensory impairment (HP:0002936) | 1.73331073 |
| 160 | Hyporeflexia of lower limbs (HP:0002600) | 1.72672266 |
| 161 | Urinary urgency (HP:0000012) | 1.72471829 |
| 162 | Postnatal microcephaly (HP:0005484) | 1.68816233 |
| 163 | Peripheral demyelination (HP:0011096) | 1.67978351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.41491452 |
| 2 | OXSR1 | 4.51267453 |
| 3 | NTRK3 | 4.22820896 |
| 4 | EPHB1 | 3.50724352 |
| 5 | DAPK2 | 3.01615052 |
| 6 | PKN1 | 2.78380216 |
| 7 | BCR | 2.64140833 |
| 8 | WNK4 | 2.52191452 |
| 9 | MAPKAPK5 | 2.51383273 |
| 10 | PBK | 2.50456707 |
| 11 | TNIK | 2.38589542 |
| 12 | MINK1 | 2.31486356 |
| 13 | CDK19 | 2.29819793 |
| 14 | PRKD3 | 2.28613655 |
| 15 | MET | 2.15813064 |
| 16 | MAP3K9 | 2.11634904 |
| 17 | FGFR2 | 2.09366161 |
| 18 | CAMKK1 | 2.08253994 |
| 19 | UHMK1 | 1.90914870 |
| 20 | WNK1 | 1.88748837 |
| 21 | LIMK1 | 1.87057200 |
| 22 | PNCK | 1.83371481 |
| 23 | CSNK1G3 | 1.75416283 |
| 24 | CSNK1A1L | 1.66909987 |
| 25 | NEK6 | 1.62539649 |
| 26 | PRPF4B | 1.60058902 |
| 27 | NTRK1 | 1.58231732 |
| 28 | TESK2 | 1.54082118 |
| 29 | CAMK2B | 1.53263876 |
| 30 | ROCK2 | 1.50719189 |
| 31 | RIPK1 | 1.49345893 |
| 32 | PLK2 | 1.48742788 |
| 33 | MST4 | 1.45703614 |
| 34 | ICK | 1.44067434 |
| 35 | LATS2 | 1.42460268 |
| 36 | CLK1 | 1.42122743 |
| 37 | CASK | 1.42121741 |
| 38 | FGR | 1.37600245 |
| 39 | CSNK1G1 | 1.35888265 |
| 40 | EPHA4 | 1.32570591 |
| 41 | TYRO3 | 1.32380899 |
| 42 | CSNK1G2 | 1.31537015 |
| 43 | CAMK2D | 1.29863464 |
| 44 | PAK6 | 1.23501322 |
| 45 | SGK223 | 1.17180188 |
| 46 | SGK494 | 1.17180188 |
| 47 | PINK1 | 1.16297861 |
| 48 | CAMK1 | 1.13852095 |
| 49 | RIPK4 | 1.10135311 |
| 50 | ALK | 1.09596272 |
| 51 | GRK5 | 1.08833335 |
| 52 | PRKCG | 1.06940991 |
| 53 | MARK1 | 1.01164641 |
| 54 | SGK2 | 1.01061887 |
| 55 | DYRK2 | 0.99397708 |
| 56 | CAMK2G | 0.98251373 |
| 57 | DAPK1 | 0.94689676 |
| 58 | CAMKK2 | 0.93657062 |
| 59 | SGK3 | 0.89465307 |
| 60 | IRAK2 | 0.86593718 |
| 61 | SGK1 | 0.86051655 |
| 62 | MAPK15 | 0.86038679 |
| 63 | CAMK2A | 0.85892187 |
| 64 | PRKCQ | 0.85664380 |
| 65 | PAK3 | 0.85326941 |
| 66 | MARK2 | 0.85194566 |
| 67 | MUSK | 0.82134859 |
| 68 | CDK5 | 0.81973309 |
| 69 | CDK14 | 0.81367696 |
| 70 | DAPK3 | 0.80586479 |
| 71 | MAPK12 | 0.80445298 |
| 72 | SIK2 | 0.80426871 |
| 73 | STK38 | 0.74549598 |
| 74 | ARAF | 0.74533885 |
| 75 | FES | 0.73185748 |
| 76 | PRKD1 | 0.72085940 |
| 77 | CDK15 | 0.70754750 |
| 78 | BMPR1B | 0.70157566 |
| 79 | BRSK1 | 0.68816565 |
| 80 | RPS6KA3 | 0.66028301 |
| 81 | MAPK13 | 0.65614700 |
| 82 | CDK18 | 0.65450839 |
| 83 | PHKG2 | 0.65383417 |
| 84 | PHKG1 | 0.65383417 |
| 85 | PRKCE | 0.65037439 |
| 86 | CDK11A | 0.63168958 |
| 87 | PDPK1 | 0.61325038 |
| 88 | FYN | 0.57902317 |
| 89 | KSR1 | 0.57693131 |
| 90 | ERBB4 | 0.56528972 |
| 91 | PRKCZ | 0.54209847 |
| 92 | TNK2 | 0.53942937 |
| 93 | CAMK4 | 0.53881484 |
| 94 | RPS6KA5 | 0.51550191 |
| 95 | NTRK2 | 0.51445294 |
| 96 | MAP3K4 | 0.50092399 |
| 97 | RET | 0.49728297 |
| 98 | KSR2 | 0.48675398 |
| 99 | PRKG1 | 0.48266888 |
| 100 | CSNK1D | 0.47736451 |
| 101 | MAP3K13 | 0.47687774 |
| 102 | LMTK2 | 0.47271808 |
| 103 | GSK3A | 0.46875979 |
| 104 | MAP3K11 | 0.46087736 |
| 105 | MAP2K2 | 0.44699225 |
| 106 | ADRBK2 | 0.42828795 |
| 107 | GRK7 | 0.42601657 |
| 108 | TRPM7 | 0.42330383 |
| 109 | BRAF | 0.42015150 |
| 110 | CSNK1A1 | 0.41635064 |
| 111 | IRAK1 | 0.40953141 |
| 112 | PRKCH | 0.39814190 |
| 113 | PDK2 | 0.38154967 |
| 114 | MAP2K4 | 0.38022039 |
| 115 | PRKACB | 0.37961026 |
| 116 | ERBB2 | 0.37885846 |
| 117 | CAMK1G | 0.37540807 |
| 118 | RAF1 | 0.37254389 |
| 119 | PDGFRB | 0.37115709 |
| 120 | PIK3CA | 0.36964590 |
| 121 | STK11 | 0.35459619 |
| 122 | PAK1 | 0.34077937 |
| 123 | MAP3K1 | 0.33323589 |
| 124 | PRKCA | 0.32987633 |
| 125 | MKNK1 | 0.32589758 |
| 126 | SRC | 0.31188272 |
| 127 | INSR | 0.30369423 |
| 128 | PRKACA | 0.30295493 |
| 129 | DMPK | 0.30227548 |
| 130 | PRKCB | 0.29540647 |
| 131 | OBSCN | 0.29434701 |
| 132 | MAP3K2 | 0.28714439 |
| 133 | PDK1 | 0.28621618 |
| 134 | BMPR2 | 0.28338434 |
| 135 | PTK2B | 0.27758612 |
| 136 | ROCK1 | 0.25639955 |
| 137 | MAPK7 | 0.24675521 |
| 138 | DYRK1A | 0.24645900 |
| 139 | CSNK1E | 0.24435233 |
| 140 | GRK1 | 0.23946481 |
| 141 | ITK | 0.23142101 |
| 142 | CSK | 0.22539999 |
| 143 | MAPK10 | 0.22431847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.57493947 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.72826729 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.38834293 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.49464639 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.18571311 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.84526425 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.52795295 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.51671475 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44487406 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.34977946 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16130712 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.93623341 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.93293405 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.85675024 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.84373516 |
| 16 | Axon guidance_Homo sapiens_hsa04360 | 1.76526970 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.74429480 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70585968 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.63888932 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58196774 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.54077693 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49449618 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47454463 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.47239258 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45296107 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40472384 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37951364 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37937987 |
| 29 | GABAergic synapse_Homo sapiens_hsa04727 | 1.36530975 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35739889 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.35624561 |
| 32 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.30349512 |
| 33 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.28850539 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28420860 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27540373 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26680283 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.23913730 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21568643 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17113159 |
| 40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.11880884 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.11796999 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07101650 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06166664 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05988494 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 1.05658635 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 1.05601808 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.04216579 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00468600 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99982433 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 0.97856509 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95432831 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94993059 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90317943 |
| 54 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87805954 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86709256 |
| 56 | Tight junction_Homo sapiens_hsa04530 | 0.84997808 |
| 57 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84259151 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83835313 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81081018 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80943097 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 0.80398804 |
| 62 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78243628 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77392923 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76661592 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74821101 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74764443 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74062387 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73182304 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72469892 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71459433 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71419632 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71398979 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71266534 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70849914 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.70508676 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70385535 |
| 77 | Phototransduction_Homo sapiens_hsa04744 | 0.68313803 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68184699 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68140493 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68127906 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67626339 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66151330 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66134945 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.64652941 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63231625 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62857915 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59955343 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59924168 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57324726 |
| 90 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57001590 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56861555 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56756179 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56635050 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.55507482 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55066046 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54887831 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54413762 |
| 98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54177932 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.53446211 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.53334462 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52906560 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51981033 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50909802 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50392684 |
| 105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49397616 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48377034 |
| 107 | Peroxisome_Homo sapiens_hsa04146 | 0.46073249 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.45153783 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44394534 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.44133579 |
| 111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43383389 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42312518 |
| 113 | Gap junction_Homo sapiens_hsa04540 | 0.41658006 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40433719 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.39894391 |
| 116 | Taste transduction_Homo sapiens_hsa04742 | 0.39814066 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39188624 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38097169 |
| 119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37785119 |
| 120 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37272396 |
| 121 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36611678 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.35807997 |
| 123 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35536588 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34357446 |
| 125 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33966915 |
| 126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33825809 |
| 127 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33232727 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32290594 |
| 129 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32163976 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32139336 |
| 131 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31022798 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30927395 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30796155 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30180748 |
| 135 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29870969 |
| 136 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.28164355 |
| 137 | Alcoholism_Homo sapiens_hsa05034 | 0.26921886 |
| 138 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26093382 |
| 139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26088765 |
| 140 | Long-term potentiation_Homo sapiens_hsa04720 | 0.25698060 |
| 141 | Malaria_Homo sapiens_hsa05144 | 0.25291371 |
| 142 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24422504 |

